2003 News

Why America Needs a Medicare Prescription Drug Benefit

By The Honorable Bob Franks, President, HealthCare Institute of New Jersey

Hillside, NJ, June 16, 2003 — In a rare display of bipartisan resolve, Congress may finally be able to pass a landmark Medicare reform bill in the next few weeks, giving seniors a much needed prescription-drug benefit. Read more

 

HINJ Interview with Congressman Rodney Frelinghuysen

Hillside, NJ, May 1, 2003 — The following is an interview between HINJ President Bob Franks and Congressman Rodney Frelinghuysen, a Republican who represents New Jersey’s 11th Congressional District. Read more

 

New HINJ Report: Economic Impact of HINJ Members Reaches All-Time High

More than $22 billion total economic impact on state

69,209 directly employed by industry

Average base salary is $80,246

Capital investment of nearly $2.4 billion

Charitable contributions totaled $45.5

Hillside, NJ, April 15, 2003 — Despite the sluggish economy, member companies of the HealthCare Institute of New Jersey (HINJ) contributed more than $22 billion to the state’s economy in 2002, surpassing previous years’ numbers, according to a study released today by HINJ.  The study — commissioned by HINJ and conducted by IBM Business Consulting Services — surveyed 20 HINJ member pharmaceutical and medical technology companies regarding their 2002 performance. Read more

 

Growing Numbers of Uninsured Underscores the Need for a Medicare Prescription Drug Benefit, Says HINJ

Hillside, NJ, March 25, 2003 — The HealthCare Institute of New Jersey (HINJ) today called on Congress to enact a Medicare Prescription Drug Benefit, which would give seniors and the disabled full access to innovative medicines that will help them live longer, healthier and more productive lives. Read more

 

Statement Regarding the New Jersey Life Sciences Super-Cluster Initiative

By The Honorable Bob Franks, President, HealthCare Institute of New Jersey

Hillside, NJ, February 14, 2003 — HealthCare Institute of New Jersey (HINJ) President Bob Franks today issued the following statement: Read more

 

HINJ Reports More Than a Third of FDA-Approved Drugs Came from New Jersey in 2002

New Brunswick, NJ, February 10, 2003 — New Jersey-based pharmaceutical companies developed more than a third of all the new medicines approved by the U.S. Food and Drug Administration (FDA) in 2002, according to statistics compiled by the HealthCare Institute of New Jersey (HINJ).  Of the 17 new drugs, 7 came from the Garden State. Read more

 

Password Reset

Please enter your e-mail address. You will receive a new password via e-mail.